USPTO serial 79131861
MINION
Reviewed by CopyMark Law Group
Reg. 4650844Status 709
- Filing date
- Status date
- Registration date
- Dec 9, 2014
- Examiner
- LEE, DOUGLAS
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MINION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Oxford Nanopore Technologies Limited
GB
Other trademarks owned by Oxford Nanopore Technologies Limited
Oxford Nanopore Technologies Limited
GB
Other trademarks owned by Oxford Nanopore Technologies Limited
Oxford Nanopore Technologies PLC
GB
Oxford Nanopore Technologies Limited
Oxford OX4 4DQ, GB
Other trademarks owned by Oxford Nanopore Technologies Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for use in automated test systems for non-medical purposes; reagents for analytical tests for non-medical purposes; reagents for industrial use, namely, for food testing, soil testing, water testing and air quality testing; reagents for use in science; reagents for laboratory use; reagents for use in molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification; reagents for use in forensic analysis; [ reagents for research purposes in the field of blood grouping; ] reagents for use in environmental testing and environmental analysis; reagents for testing water and other liquids; reagents for testing aqueous solutions; reagents for processing biological elements prior to their use with or analysis by scientific apparatus; reagents for use in nucleic acid characterisation and nucleic acid sequencing for non-medical purposes; reagents for protein identification and analysis for non-medical purposes; chemicals for use in tests to detect diseases in plant life; reagents for formation of amphipathic membranes; chemicals, namely, buffer solutions for scientific or research use; [ aqueous solvents for industrial and commercial use; non-aqueous solvents for industrial and commercial use; ] non-aqueous media in the nature of solid or liquid non-aqueous solutions for scientific or research use; [ surfactants for use in analytical tests for scientific or research use; silicone oils for analytical tests for scientific or research use; silicone fluids; ] enzymes for scientific and research purposes and use in analytical tests; proteins for use in analytical tests for scientific or research use; chemical diagnostic reagents for scientific use, all the foregoing for other than medical and veterinary purposes; reagents for medical and veterinary research; nucleic acid amplification reagents for medical research or forensic use | SECTION 71 - CANCELLED | — |
| 005 | Reagents for veterinary or medical use; reagents for use in automated test systems for veterinary or medical use; reagents, namely, reagents for use in blood grouping, molecular biology, bacteriological, biotechnology and microbiological analysis, including reagents for formation of amphipathic membranes, buffer solutions, non-aqueous solvents, and surfactants, all for medical or veterinary use; reagents for medical and veterinary diagnosis; reagents for laboratory tests for medical or veterinary purposes; reagents for medical or veterinary use, namely, reagents for immunoassay analysers; reagents for medical or veterinary use, namely, reagents for testing aqueous solutions; medical and veterinary diagnostic reagents for testing for susceptibility to allergies; reagents for medical or veterinary use, namely, reagents for use in biological processing; reagents for medical or veterinary use, namely, reagents for use in nucleic acid characterisation and nucleic acid sequencing; reagents for medical or veterinary use, namely, reagents for protein identification and analysis; [ reagents for medical or veterinary use, namely, reagents for formation of amphipathic membranes; blood substitute in the form of buffer solutions for medical and veterinary use; aqueous solvents for use in tests for medical and veterinary purposes; non-aqueous solvents for use in tests for medical and veterinary purposes; non-aqueous media in the nature of solid or liquid non-aqueous solutions for use in tests for medical and veterinary purposes; surfactants for use in tests for medical and veterinary purposes; silicone oils for use in tests for medical and veterinary purposes; ] enzymes for use in tests for medical and veterinary purposes; proteins for use in tests, all the foregoing for medical and veterinary purposes | SECTION 71 - CANCELLED | — |
| 009 | Apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; diagnostic and testing apparatus, for testing air quality, food, soil or water, not for medical purposes; computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; instruments and apparatus for the display of information obtained from scientific equipment, namely, electronic display interfaces; silicon chips; DNA chips; microarray chips; analyte detector chips for scientific or research use; biosensor chips for scientific or research use; laboratory equipment, namely, empty cartridges for use with concentrates and solutions in solid or liquid form samples for use in biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis; batteries; rechargeable batteries; chargers for batteries; power packs consisting of batteries; computer docking stations; apparatus for connecting and charging portable digital electronic devices; diagnostic apparatus incorporating chemical or biological reagents for testing air quality, food, soil or water; reaction systems containing chemical or biological reagents for laboratory use; parts and fittings for all the aforesaid goods | SECTION 71 - CANCELLED | — |
| 010 | Medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; portable medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for pregnancy testing and for detecting for pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for medical testing use; reaction units containing chemical reagents, for medical testing purposes; parts and fittings for all the aforesaid goods | SECTION 71 - CANCELLED | — |
| 042 | [ Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services, namely, biological, chemical, biochemical, bacteriological DNA, RNA, protein, polynucleic acid and molecular analysis for scientific or research purposes; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services for chemical, biochemical, biological, bacteriological, molecular analysis, medical or veterinary purposes; DNA and polynucleic acid testing services for scientific or research purposes; information and advice regarding all the aforesaid services ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks owned by Oxford Nanopore Technologies PLC
- Other trademarks owned by Oxford Nanopore Technologies Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named MINION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 6, 2026 | C71T | CANCELLED SECTION 71 | — |
| Jul 1, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 9, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 23, 2023 | FINP | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 21, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 21, 2023 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 21, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 27, 2022 | FINV | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 5, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Aug 3, 2022 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 30, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 1, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 1, 2021 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Nov 29, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 10, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 10, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 8, 2021 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 9, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 13, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 10, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 16, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 30, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 30, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 9, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 9, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 23, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 11, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 3, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 3, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 19, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 19, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 12, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 11, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 11, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 31, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 18, 2014 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 14, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 6, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2014 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 3, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jan 23, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 26, 2013 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Aug 23, 2013 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Aug 11, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 19, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 18, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 9, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |